Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

30/06/2009 30/06/2008 Unaudited consolidated statement of financial position In '000 Euro - According to IFRS ASSETS: Property plant and equipment 960 934 Intangible Assets 7,756 - Goodwill 2,586 2,586 Fixed Assets: 11,302 3,520 Trade and other receivables 2,442 32,236 Investments 5,721 6,684 Cash and cash equivalents 46,866 33,614 Current Assets 55,029 72,534 Pension 73 39 Long-term Assets 73 39 Total Assets 66,404 76,093 EQUITY AND LIABILITIES Share capital 113,997 111,086 Share premium 15,907 15,733 Accumulated translation differences 39 13 Other reserves (20,235) (21,199) Retained earnings (48,622) (38,026) Equity attributable to equity holders of the parent 61,086 67,607 Minority interests - - Total Equity 61,086 67,607 Trade payables 4,246 7,380 Other short-term liabilities 1,072 1,106 Short-term liabilities 5,318 8,486 Total Equity and Liabilities
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015   BioClinica ® , Inc., a ... that David Peters , an accomplished senior finance ... and Chief Financial Officer (CFO) and will be joining ... more than 25 years of financial and accounting experience ... and deep knowledge in all areas of finance, accounting ...
(Date:6/2/2015)... 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO ) ... leading provider of cord blood collection, laboratory testing, ... announced that the Special Committee of the Company,s board of ... ( China ) Limited as its independent financial ... its United States legal counsel and ...
(Date:6/2/2015)... 2015 MGB Biopharma at ... problem  MGB Biopharma, a biopharmaceutical company ... address the major global problem of antibiotic resistance ... intravenous (IV) formulation of MGB-BP-3, designed for the treatment ... The intravenous formulation of MGB-BP-3 is currently ...
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
Breaking Biology Technology:BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3
... at the atomic scale. Source: Imago The ... for nanotechnology research, said it has commissioned an instrument ... , ,NANO officials said they were pleased with the ... the University of Sydney. , ,Imago makes tools to ...
... waves had barely receded in Indonesia, Thailand and Sri Lanka ... the wealthier nations of the world stingy for not providing ... another reason to dislike the UN. Others responded by doing ... and wallets. , ,The past weeks predictable yes, predictable ...
... realm of content management systems (CMS) providers, Northwoods ... for clients. Forget the gearhead techno-speak. The Milwaukee area ... issues through plain talk and better Web design. , ... Web, said Pat Bieser, founder and CEO of the ...
Cached Biology Technology:Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3Untangling the Web: Northwoods Software in profile 2Untangling the Web: Northwoods Software in profile 3Untangling the Web: Northwoods Software in profile 4Untangling the Web: Northwoods Software in profile 5
(Date:5/14/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) ... Market in Smart Mobile Devices " report to ... was a watershed year for fingerprint sensors in smartphones ... Apple gave fingerprint sensors a raison d,etre in the ... are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... in hot and dry climates could make passengers more comfortable ... according to a study published in the International Journal ... Department of Mechanical Engineering, at the Indian Institute of Technology ... passenger trips are taken in open window buses. Worldwide, ...
... continues to puzzle scientists, long after the 200 years ... consistent patterns of biodiversity have been identified over space, ... of the process of "speciation" -- the evolutionary process ... theory. The first requires a physical barrier such as ...
... ice formation occurred in the Arctic earlier than previously ... week in Nature . "The results are also ... in the Arctic before it did in Antarctica, which ... Richard Pearce of the University of Southampton,s School of ...
Cached Biology News:Slotted buses keep passengers cool 2A global model for the origin of species independent of geographical isolation 2Early initiation of Arctic sea-ice formation 2Early initiation of Arctic sea-ice formation 3
... Molecular Probes intensely fluorescent and highly ... for use in a variety of ... a strong signal. Unfortunately, protein- and ... that may cause them to bind ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... Description: Proteinase K is a highly active and ... applications purified from the fungus T. album. It ... of N-substituted hydrophobic aliphatic and aromatic amino acids ... protease. Proteinase K is useful in purifying high ...
...
Biology Products: